1. CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling. Issue 7 (26th July 2022) Authors: Fix, Samantha M; Forget, Marie-Andrée; Sakellariou-Thompson, Donastas; Wang, Yunfei; Griffiths, Tamara M; Lee, Minjung; Haymaker, Cara L; Dominguez, Ana Lucía; Basar, Rafet; Reyes, Christopher; Kumar, Sanjay; Meyer, Larissa A; Hwu, Patrick; Bernatchez, Chantale; Jazaeri, Amir A Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗